Digital family program for weight control in young people with chronic illness
Tests a digital weight program for young people with obesity and diabetes or asthma.
Plain-language title generated from the registry record
Registry title: DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
Key facts
- Where
- Seville, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult caregivers of a young person aged 12 to 21 years who has type 1 diabetes or asthma. The young person may have normal weight or overweight/obesity, as set out below.
- Age
- Caregiver aged 18 years or older. The young person they care for is aged 12 to 21 years.
- Sex
- All sexes can join.
- Disease stage
- The young person has type 1 diabetes with normal weight (BMI between the 10th and 85th percentile) or with overweight/obesity (BMI of 85th percentile or higher). Or the young person has asthma with overweight/obesity (BMI of 85th percentile or higher).
Main reasons for not taking part
- Severe psychiatric or cognitive conditions that would interfere with the digital program
- Taking part now in another digital health study on obesity or chronic disease
- Cannot or will not follow the study procedures
- Refuses or cannot give informed consent
Read by machine on 12 November 2026.
Where in Spain
- Adhera Health (Virtual Participation)Seville, SpainContact: Sara BelónTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Adhera Health, Inc.
- Trial code
- NCT07638345
- Record updated
- 23 June 2026
- Original description
This prospective single-arm feasibility study evaluates the Adhera Caring Digital Program for Obesity (ACDP-O), a family-centered digital health intervention designed to support adolescents and young adults with overweight/obesity and chronic conditions, including type 1 diabetes (T1D) and asthma. The intervention combines personalized educational content, wearable-device monitoring, psychometric assessments, and explainable artificial intelligence (AI) to improve mental well-being, quality of life, and adherence to healthy lifestyle behaviors. A total of 280 families will participate in a 3-month intervention with remote monitoring and follow-up assessments.Read full original descriptionShow less
US-based Clinical Sub-study of DASH-Obesity: Explainable AI for Family-Centric Transdiagnostic Personalized Weight Control Across Multiple Conditions
This prospective single-arm feasibility study evaluates the Adhera Caring Digital Program for Obesity (ACDP-O), a family-centered digital health intervention designed to support adolescents and young adults with overweight/obesity and chronic conditions, including type 1 diabetes (T1D) and asthma. The intervention combines personalized educational content, wearable-device monitoring, psychometric assessments, and explainable artificial intelligence (AI) to improve mental well-being, quality of life, and adherence to healthy lifestyle behaviors. A total of 280 families will participate in a 3-month intervention with remote monitoring and follow-up assessments.
Inclusion: Adult caregiver (aged 18 years or older) of an adolescent or young adult aged 12 to 21 years diagnosed with Type 1 Diabetes (T1D) or asthma; The caregiver is actively involved in the management of the adolescent's or young adult's condition; The adolescent or young adult must meet one of the following criteria:; T1D and normal weight (BMI between the 10th and 85th percentile), or; T1D and overweight/obesity (BMI ≥85th percentile), or; Asthma and overweight/obesity (BMI ≥85th percentile); Willingness to participate in the Adhera Caring Digital Program-Obesity (ACDP-O); Access to a smartphone or internet-enabled device compatible with the study application; Willingness to provide self-reported information regarding the adolescent's or young adult's health status, including disease-related and anthropometric measures; For caregivers of participants with T1D, willingness to share continuous glucose monitoring (CGM) information.
Exclusion: Severe psychiatric or cognitive conditions that would interfere with participation in the digital intervention; Current participation in another obesity- or chronic disease-related digital health intervention study; Inability or unwillingness to comply with study procedures; Refusal or inability to provide informed consent.